Fabre-Kramer Pharmaceuticals
Manufacturing · Texas, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
5847 San Felipe St Ste 2000, Houston, Te...Phone Number
(713) 975-6900Website
www.fabrekramer.comRevenue
<$5 MillionIndustry
About Fabre-Kramer Pharmaceuticals
Fabre-Kramer Pharmaceuticals, Inc. specializes in the identification, development, and commercialization of psychotropic drugs aimed at treating psychiatric and neurologic disorders. The company is currently focused on the commercial launch of its lead product, Gepirone Hydrochloride. Their intended clients include healthcare providers and patients in need of psychiatric and neurologic treatments. Fabre-Kramer is recognized as a leader in the pharmaceutical industry for its innovative approaches to mental health care.Explore more
Fabre-Kramer Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Fabre-Kramer Pharmaceuticals
Compare insights from companies similar to Fabre-Kramer Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Fabre-Kramer Pharmaceutic...
<$5M
1-10
Private
-
1992
JS
Jennifer SpringDirector, Global Commercial Operations
Fabre-Kramer Pharmaceuticals Tech Stack
A closer look at the technologies used by Fabre-Kramer Pharmaceuticals
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Fabre-Kramer Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Fabre-Kramer Pharmaceuticals, Inc. specializes in the identification, development, and commercialization of psychotropic drugs aimed at treating psychiatric and neurologic disorders. The company is currently focused on the commercial launch of its lead product, Gepirone Hydrochloride. Their intended clients include healthcare providers and patients... Read More
